SLC25A52
Mitochondrial nicotinamide adenine dinucleotide transporter SLC25A52
Also known as: MCART2, S2552_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3SY17
- Gene
- SLC25A52
- Ensembl
- ENSG00000141437
- Chromosome
- 18
- Canonical length
- 297 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene is similar to the mitochondrial carrier triple repeat 1 gene on chromosome 9. The gene is intronless and may be an evolving pseudogene; however, it is transcribed and it contains a full-length coding region so it is currently classified as a protein-coding locus. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q3SY17|SLC25A52
1 MIDSEAHEKR PPILTSSKQD ISPHITNVGE MKHYLCGCCA AFNNVAITYP IQKVLFRQQL
61 YGIKTRDAVL QLRRDGFRNL YRGILPPLMQ KTTTLALMFG LYEDLSCLLR KHVRAPEFAT
121 HGVAAVLAGT AEAIFTPLER VQTLLQNHKH HDKFTNTYQA FKALKCHGIG EYYRGLVPIL
181 FRNGLSNVLF FGLRGPIKEH LPTATTHSAH LVNDFIGGGL LGAMLGFLCF PINVVKTRLQ
241 SQIGGEFQSF PKVFQKIWLE RDRKLINLFR GAHLNYHRSL ISWGIINATY EFLLKFILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC25A52 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 9.7 nTPM
Expression across tissuesHPA
Tissue
- testis: 9.7 nTPM
- liver: 0.6 nTPM
- skeletal muscle: 0.5 nTPM
- adipose tissue: 0.2 nTPM
- pituitary gland: 0.2 nTPM
- adrenal gland: 0.1 nTPM
Single-cell type
- late spermatids: 164 nCPM
- late primary spermatocytes: 58 nCPM
- early spermatids: 49 nCPM
- early primary spermatocytes: 2.3 nCPM
- sertoli cells: 1.1 nCPM
- undifferentiated spermatogonia: 1.1 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- medulla oblongata: 1.3 nTPM
- pons: 1.2 nTPM
- cerebral cortex: 1.1 nTPM
- choroid plexus: 1 nTPM
- hippocampal formation: 1 nTPM
- hypothalamus: 1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC25A52 as an antibody target. Whether an autoantibody or antibody against SLC25A52 could matter depends on whether native SLC25A52 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC25A52 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC25A52 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...